Target intelligence / Profile preview

Gram-negative bacterial outer membrane components (Lipopolysaccharide and Phospholipids) (LPS)

Target
LPS
Molecular classification
Bacterial cell wall/membrane component, Lipid, Glycolipid
01

Overview

The Gram-negative bacterial outer membrane is a specialized asymmetric lipid bilayer that functions as a vital permeability barrier, shielding the bacterium from toxic substances and host immune defenses [6, 10]. Its outer leaflet is predominantly composed of lipopolysaccharides (LPS), while the inner leaflet consists of phospholipids [10, 13]. LPS is a complex glycolipid comprising lipid A, a core oligosaccharide, and an O-antigen; lipid A acts as a potent endotoxin that triggers the host's innate immune system via the Toll-like receptor 4 (TLR4) pathway [9, 12, 18]. Therapeutic agents such as polymyxins exploit the negative charge of LPS and phospholipids to bind and destabilize the membrane, causing lethal leakage of cellular components [1, 3, 4]. However, the clinical use of such drugs is often limited by significant safety concerns, including nephrotoxicity and neurotoxicity, as well as the risk of inducing severe inflammatory reactions like the Jarisch-Herxheimer reaction due to the rapid release of endotoxins during bacterial lysis [1, 4, 5].

Other names
EndotoxinLipid AGram-negative outer membraneBacterial cell envelope componentsLipopolysaccharide
02

Mechanism of action

Drugs targeting these components typically bind to the negatively charged lipid A portion of LPS and the phospholipids, displacing divalent cations (Mg2+ and Ca2+) that stabilize the membrane. This leads to increased membrane permeability, disruption of the bilayer structure, and leakage of intracellular contents, ultimately resulting in bacterial cell death [1, 3, 4].

03

Biological functions

Structural integrityPermeability barrierImmune response inductionEndotoxin activityCell-surface interaction
04

Disease associations

InfectionSepsisSeptic shockInflammation
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionSystemic inflammatory response syndrome (SIRS)
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinLipopolysaccharide-binding protein (LBP)Endotoxin levels

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane components (Lipopolysaccharide and Phospholipids) (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane components (Lipopolysaccharide and Phospholipids) (LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call